The histone deacetylase (HDAC) inhibitor MS.275 (Entinostat), which is highly specific for class 1 HDACs, selectively induces apoptosis in cancer cells by combining with tetrandrine, but normal cells are unaffected (Li H. et al., 2020). The gene discussed is HDAC9; the disease is cancer.